Skip to main content
Wellcome Sanger Institute
Careers | Find us | Contact us
  • About
    • Our Vision
    • Impact
    • Careers
    • Study
    • Equality, Diversity and Inclusion
    • Leadership
    • Strategy and Funding
    • Influencing Policy
    • Research Policies
    • Branding and Logos
    • Admin Groups
    • Campus Connections
  • Science
    • Groups
    • Programmes
    • Collaborations
    • Tools
    • Data
    • Sanger Projects
    • COVID-19
    • Publications
    • Research Policies
    • Sanger Seminar Series
  • People
    • Leadership
    • Faculty
    • Associate Faculty
    • Honorary Faculty
    • International Fellows
    • Science Staff
    • Non-science Staff
    • Full A-Z
  • Innovation
    • Innovation at the Institute
    • For Industry
    • For Researchers
    • Case Studies
    • Our Spin-Outs
    • Sanger Technologies
  • News

We apply and explore genomic technologies at scale to advance understanding of biology and improve health

  • Leading UK and South African genomics labs unite to take disease surveillance beyond COVID

    Building on genomic surveillance success during the pandemic, this close collaboration will track more pathogens in more places

    Find out more

  • Antibiotic use is not the only driver of superbugs

    Researchers have analysed the rise of antibiotic resistance over the last 20 years in the UK and Norway, highlighting that antibiotic use is not the only factor in the increase.

    Find out more

  • Cancer drug discovery accelerated as hundreds of overlooked targets prioritised 

    The second generation of the Cancer Dependency Map uncovers 370 priority drug targets, with strong links to specific cancer types.

    Find out more

  • New methodology unifies single-cell data

    CellHint can unify different single-cell data, creating harmonised, applicable datasets for the study of human health and disease.

    Find out more

  • Secret vulnerabilities of cancer's 'Death Star' revealed

    KRAS is one of the most frequently mutated genes in cancer. Researchers expose its secret vulnerabilities, laying out a fresh blueprint for targeting ‘undruggable’ proteins.

    Find out more

Wellcome Sanger Institute

Meet our people: Life at the Sanger Institute

We have over 1,200 people at the Sanger Institute, from 70+ nationalities. We know that the success of our Institute depends on our people.

Explore what our employees, students, and alumni from across the Institute have to say about what they do, our culture and more.

Wellcome Sanger Institute

Our 2022/2023 Highlights document

Our Highlights document showcases the key discoveries and future research interests of our Scientific Programmes. These include vital insights into human, parasite and microbe evolution, cellular growth and activity, and the processes that underlie mutation and tumour formation. In addition, our Tree of Life Programme explores the diversity of complex life. ...more

 

Latest News and Blogs

29 Jan 2024

2024 Winners: Accelerator Awards for Postdocs

Meet the four winners of our Sanger Accelerator Awards for Postdocs (SAAPs) to accelerate postdocs along their career trajectory

Luke Lythgoe, Genomic Surveillance Unit, Wellcome Sanger Institute

25 Jan 2024

Leading UK and South African genomics labs unite to take disease surveillance beyond COVID

Building on genomic surveillance success during the pandemic, this close collaboration will track more pathogens in more places

18 Jan 2024

Hacking for the single-cell universe

A recent hackathon, hosted by the Wellcome Sanger Institute, brought together software developers and computational biologists working on tools to analyse data from single cells.

Sanger Logo

Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244

  • About
  • Legal
  • Data sharing
  • Careers
  • Privacy
  • Equality, Diversity, Inclusion
  • Study
  • Modern Slavery Statement
ROSPA Gold
Athena Swan

Expand footer

Wellcome Sanger Institute, Genome Research Limited (reg no. 2742969) is a charity registered in England with number 1021457

2024 Wellcome Sanger Institute | All rights reserved